A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
Public ClinicalTrials.gov record NCT00656890. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Subjects With Active Ulcerative Colitis
Study identification
- NCT ID
- NCT00656890
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- sterile saline for injection Biological
- MDX-1100 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Aug 31, 2009
- Completion
- Aug 31, 2009
- Last update posted
- Oct 11, 2015
2008 – 2009
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Medical Research Center | Port Orange | Florida | 32127 | — |
| Florida Medical Clinic-Tampa Clinic | Tampa | Florida | 33613 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Dayton Science Institute | Dayton | Ohio | 45415 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00656890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00656890 live on ClinicalTrials.gov.